DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Abraxane (Paclitaxel) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (32)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Abraxane (Paclitaxel) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 32   Next >>

Possible Abraxane side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-13

Patient: 48 year old female, weighing 64.0 kg (140.8 pounds)

Reactions: Stomatitis, Vomiting, Nausea, Anaemia, Bone Pain, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Neurotoxicity, Neuropathy Peripheral, Diarrhoea, Cardiotoxicity, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-07

Patient: 30 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Diarrhoea, Pain, Anaemia, Alopecia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 260 milligram/sq. meter
    Start date: 2011-05-12
    End date: 2011-08-23

Abraxane
    Start date: 2011-09-14
    End date: 2012-01-04

Other drugs received by patient: Herceptin; Herceptin; Neulasta; Epogen; Avastin; Antiemetics



Possible Abraxane side effects in female

Reported by a physician from Germany on 2012-08-07

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Breast Cancer Metastatic, Cerebral Disorder, Anaemia, General Physical Health Deterioration, Neutropenia, Asthenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Abraxane
    Start date: 2011-06-27
    End date: 2011-06-27

Abraxane
    Start date: 2011-06-06
    End date: 2011-06-06

Abraxane
    Start date: 2011-07-18
    End date: 2011-07-18

Other drugs received by patient: Antiemetic Drugs; Antiemetic Drugs; Antiemetic Drugs



Possible Abraxane side effects in 68 year old female

Reported by a physician from Germany on 2012-08-07

Patient: 68 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Vomiting, Nausea, Anaemia, Pain, General Physical Health Deterioration, Pyrexia, Transaminases Increased, Myalgia, Breast Cancer Metastatic, Arthralgia, Alopecia, Blood Creatinine Increased, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in 43 year old female

Reported by a physician from United States on 2012-07-30

Patient: 43 year old female, weighing 121.0 kg (266.2 pounds)

Reactions: Vomiting, Dyspnoea, Nausea, Anaemia, Hypokalaemia, Diarrhoea, Hypophagia, Dehydration, NO Therapeutic Response, Fluid Intake Reduced

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 100mg/m2 weekly iv
    Indication: Breast Cancer
    Start date: 2012-03-26
    End date: 2012-05-11

Carboplatin
    Dosage: auc 4.5 qwk iv
    Indication: Breast Cancer
    Start date: 2012-03-26
    End date: 2012-05-04

Other drugs received by patient: Depakote; Metformin Hydrochloride; Compazine; Crestor; Detrol; Hydrochlorothiazide; Prozac; Motrin



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27

Patient: female, weighing 85.8 kg (188.8 pounds)

Reactions: Nephrolithiasis, Anaemia, Hyperuricaemia, Pneumonitis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 228 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-03-15

Abraxane
    Dosage: 228 milligram
    Start date: 2012-03-15

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Other drugs received by patient: Neulasta; Neulasta; Allopurinol; Allopurinol; Vancomycin; Tolterodine Tartrate; Lorazepam; Lisinopril; Hydrocodone Bitartrate + Acetaminophen; Vancomycin; Pantoprazole; Heparin; Citalopram Hydrobromide; Celebrex; Zofran; Augmentin '125'; Albumin; Dilaudid; Morphine; Fentanyl; Compazine; Flomax; Pantoprazole; Heparin; Insulin Lispro; Lansoprazole; Potassium Chloride; Zosyn; Azithromycin; Heparin; Desmopressin Acetate; Epinephrine; Lansoprazole; Sodium Bicarbonate; Vecuronium Bromide; Trazodone HCL; Nystatin; Potassium Chloride; Levofloxacin; Calcium Gluconate; Chlorhexidine Gluconate; Nystatin; Zosyn; Acetylcysteine; Lansoprazole; Propofol



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: female, weighing 85.8 kg (188.8 pounds)

Reactions: Nephrolithiasis, Anaemia, Pneumonitis, Hyperuricaemia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 228 milligram
    Start date: 2012-03-15

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-03-15

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Abraxane
    Dosage: 228 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Other drugs received by patient: Hydrocodone; Allopurinol; Allopurinol; Zosyn; Levofloxacin; Acetylcysteine; Lansoprazole; Lansoprazole; Vecuronium Bromide; Dilaudid; Lorazepam; Citalopram Hydrobromide; Nystatin; Neulasta; Potassium Chloride; Zosyn; Heparin; Heparin; Epinephrine; Morphine; Propofol; Trazodone HCL; Nystatin; Desmopressin Acetate; Vancomycin; Vancomycin; Chlorhexidine Gluconate; Compazine; Zofran; Augmentin '125'; Albumin (Human); Sodium Bicarbonate; Neulasta; Flomax; Whole Blood; Tolterodine Tartrate; Fentanyl; Lisinopril; Pantoprazole; Pantoprazole; Heparin; Calcium Gluconate; Insulin Lispro; Lansoprazole; Celebrex; Potassium Chloride; Azithromycin



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: female, weighing 85.8 kg (188.8 pounds)

Reactions: Dyspnoea, Anaemia, Hyperuricaemia, Nephrolithiasis, Hypoxia, Blood Creatinine Increased, Renal Failure Acute, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-03-15

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Abraxane
    Dosage: 228 milligram
    Start date: 2012-03-15

Abraxane
    Dosage: 228 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Other drugs received by patient: Zofran; Allopurinol; Allopurinol; Flomax; Zosyn; Calcium Gluconate; Lorazepam; Trazodone HCL; Lisinopril; Potassium Chloride; Pantoprazole; Heparin; Nystatin; Neulasta; Vancomycin; Heparin; Tolterodine Tartrate; Neulasta; Compazine; Levofloxacin; Citalopram; Celebrex; Hydrocodone; Augmentin '125'; Albumin (Human); Pantoprazole; Azithromycin; Nystatin; Potassium Chloride; Zosyn; Whole Blood; Vancomycin; Heparin; Insulin Lispro



Possible Abraxane side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient:

Reactions: Tinnitus, Transaminases, Anaemia, Lymphopenia, Hyponatraemia, Rash, Neuropathy Peripheral, Diarrhoea, Neutropenia, Thrombocytopenia, Leukopenia, Infection

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient:

Reactions: Stomatitis, Pancreatic Carcinoma, Nausea, Anaemia, Neuropathy Peripheral, Renal Failure, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Hypertension

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 5 milligram/kilogram

Abraxane
    Dosage: 100 milligram/sq. meter

Fluorouracil
    Dosage: 180 milligram/sq. meter

Oxaliplatin
    Dosage: 75 milligram/sq. meter

Leucovorin Calcium
    Dosage: 20 milligram/sq. meter



Possible Abraxane side effects in 56 year old

Reported by a individual with unspecified qualification from United States on 2012-06-11

Patient: 56 year old

Reactions: Anaemia, Urosepsis, Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Abraxane

Abraxane
    Dosage: 100 milligram/sq. meter
    Start date: 2007-01-01

Carboplatin
    Start date: 2007-01-01

Carboplatin



Possible Abraxane side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11

Patient: 56 year old female

Reactions: Incontinence, Anaemia, Urosepsis, Hydrocephalus, Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 100 milligram/sq. meter
    Indication: Breast Cancer Metastatic
    Start date: 2007-01-01
    End date: 2007-01-01

Carboplatin
    Dosage: auc6, 1hour infusion on day 1
    Indication: Breast Cancer Metastatic
    Start date: 2007-01-01

Carboplatin
    Dosage: auc2
    Start date: 2007-01-01
    End date: 2007-01-01



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-06-08

Patient: female

Reactions: Fatigue, Anaemia, Alopecia, Deafness, Cystitis, Thrombocytopenia

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Iron; Neupogen; Whole Blood



Possible Abraxane side effects in female

Reported by a physician from Spain on 2012-06-07

Patient: female

Reactions: Vomiting, Nausea, Anaemia, Death, Fatigue, Diarrhoea, Pancreatic Carcinoma Metastatic, Alopecia, Neutropenia, Thrombocytopenia, Asthenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Transfusion



Possible Abraxane side effects in 56 year old

Reported by a physician from United States on 2012-06-05

Patient: 56 year old

Reactions: Anaemia, Urosepsis, Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin

Abraxane
    Dosage: 100 milligram/sq. meter
    Start date: 2007-01-01

Carboplatin
    Start date: 2007-01-01

Abraxane



Possible Abraxane side effects in female

Reported by a physician from Spain on 2012-06-04

Patient: female

Reactions: Death, Fatigue, Vomiting, Nausea, Anaemia, Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Neupogen



Possible Abraxane side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient:

Reactions: Weight Decreased, Thrombosis, Tachycardia, Headache, Tricuspid Valve Incompetence, Pericardial Effusion, Hot Flush, Amenorrhoea, Dyspepsia, Upper Respiratory Tract Infection, Oedema Peripheral, Temperature Intolerance, Cough, Epistaxis, Anaemia, Oral Infection, Convulsion, Insomnia, Vision Blurred, Neutropenia, Jaundice, Cardiac Tamponade, Conjunctivitis, Bone Pain, Pelvic Pain, Abdominal Pain Upper, Fatigue, Neuropathy Peripheral, Skin Discolouration, Chest Pain, Oedema, Depression, Gastrooesophageal Reflux Disease, Thrombocytopenia, Lymphoedema, Pharyngitis, Decreased Appetite, Renal Failure Acute, Vomiting, Nausea, Heart Valve Incompetence, Palmar-Plantar Erythrodysaesthesia Syndrome, Rhinorrhoea, Scotoma, Rash, Mucosal Inflammation, Anxiety, Dysgeusia, Diarrhoea, Breast Abscess, Alopecia, Hypertension, Infection, Influenza Like Illness

Drug(s) suspected as cause:
Abraxane
    Dosage: 150 milligram/sq. meter

Bevacizumab
    Dosage: 10 milligram/kilogram

Gemcitabine
    Dosage: 1500 milligram/sq. meter



Possible Abraxane side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29

Patient: 56 year old female

Reactions: Vomiting, Neurological Decompensation, Anaemia, Mental Status Changes, Headache, Incontinence, Urosepsis, Neutropenia, Hydrocephalus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc2
    Start date: 2007-01-01
    End date: 2007-01-01

Abraxane
    Dosage: 100 milligram/sq. meter
    Indication: Breast Cancer Metastatic
    Start date: 2007-01-01
    End date: 2007-01-01

Carboplatin
    Dosage: auc6, 1hour infusion on day 1
    Indication: Breast Cancer Metastatic
    Start date: 2007-01-01



Possible Abraxane side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07

Patient: 54 year old female, weighing 68.1 kg (149.7 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 80 milligram/sq. meter
    Start date: 2011-10-13

Carboplatin
    Dosage: 6 dosage forms
    Indication: Breast Cancer
    Start date: 2011-08-11

Doxorubicin HCL
    Dosage: 60 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-11-10

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-11-10

Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-08-11
    End date: 2011-10-06

Neulasta
    Indication: Chemotherapy

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-08-11



Possible Abraxane side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-16

Patient: male, weighing 103.5 kg (227.7 pounds)

Reactions: Cellulitis, Anaemia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alimta
    Dosage: 500mg/m2, then 400mg/m2 every 3 weeks iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-06-30
    End date: 2011-12-28

Abraxane
    Dosage: 260mg/m2, then 195mg/m2 every 3 weeks iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-06-30
    End date: 2011-09-28



Possible Abraxane side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Diarrhoea, Lymphatic Disorder, Anaemia, Platelet Count Decreased, Febrile Neutropenia, Cardiac Disorder

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Doxorubicin HCL
    Dosage: 10 milligram/sq. meter
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Neulasta
    Dosage: 6 milligram
    End date: 2011-08-25

Other drugs received by patient: Metoprolol Tartrate; Famotidine; Guaifenesin; Zolpidem; Cefepime; Fluconazole; Prochlorperazine; Bacitracin; Whole Blood; Benzonatate; Acetaminophen



Possible Abraxane side effects in 44 year old female

Reported by a physician from United States on 2012-01-30

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Type 2 Diabetes Mellitus, Lymphatic Disorder, Anaemia, Pancytopenia, Febrile Neutropenia, Cardiac Disorder, Diarrhoea, Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Neulasta
    Dosage: 6 milligram
    Indication: Breast Cancer
    End date: 2011-08-25

Abraxane
    Dosage: 80 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Other drugs received by patient: Ambien; Pepcid; Mucinex; Tessalon; Toprol-XL; Bacitracin; Prochlorperazine; Armodafinil; Acetaminophen; Cefepime



Possible Abraxane side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-20

Patient: male, weighing 103.5 kg (227.7 pounds)

Reactions: Cellulitis, Anaemia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 360mg/m2, then 195mg/mw every 3 weeks iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-06-30
    End date: 2011-09-28

Alimta
    Dosage: 500mg/m2, then 400mg/m2 every 3 weeks iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-06-30
    End date: 2011-12-28



Possible Abraxane side effects in

Reported by a health professional (non-physician/pharmacist) from Singapore on 2011-12-21

Patient:

Reactions: Vomiting, Nausea, Anaemia, Febrile Neutropenia, Hypocalcaemia, Neutropenia, Decreased Appetite

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in 44 year old female

Reported by a physician from United States on 2011-12-13

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Diarrhoea, Lymphatic Disorder, Anaemia, Febrile Neutropenia, Platelet Count Decreased, Cardiac Disorder

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Doxorubicin HCL
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Abraxane
    Dosage: 80 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Pegfilgrastim
    Dosage: 6 milligram
    Indication: Breast Cancer
    End date: 2011-08-25

Other drugs received by patient: Cefepime; Pepcid; Diflucan; Bacitracin; Mucinex; Tessalon; Ambien; Toprol-XL; Prochlorperazine; Acetaminophen



Possible Abraxane side effects in

Reported by a individual with unspecified qualification from China on 2011-12-06

Patient:

Reactions: Hepatic Function Abnormal, Neuropathy Peripheral, Fatigue, Alopecia, Anaemia, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in 44 year old female

Reported by a physician from United States on 2011-11-29

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Diarrhoea, Lymphatic Disorder, Anaemia, Platelet Count Decreased, Febrile Neutropenia, Cardiac Disorder

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Pegfilgrastim
    Dosage: 6 milligram
    Indication: Breast Cancer
    End date: 2011-08-25

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Abraxane
    Dosage: 80 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Other drugs received by patient: Cefepime; Prochlorperazine; Diflucan; Bacitracin; Mucinex; Pepcid; Tessalon; Acetaminophen; Ambien; Toprol-XL



Possible Abraxane side effects in 50 year old female

Reported by a physician from United States on 2011-11-29

Patient: 50 year old female, weighing 77.2 kg (169.8 pounds)

Reactions: Anaemia, Acute Myeloid Leukaemia, Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Pegfilgrastim
    End date: 2009-03-19

Doxorubicin HCL
    End date: 2009-03-19

Abraxane
    Dosage: 80 milligram
    Indication: Breast Cancer
    End date: 2009-01-07

Cyclophosphamide
    Dosage: 600 milligram
    Indication: Breast Cancer
    Start date: 2008-08-20
    End date: 2008-10-08

Cyclophosphamide
    End date: 2009-03-19

Filgrastim
    Dosage: 5 milligram
    Indication: Breast Cancer
    Start date: 2008-08-20
    End date: 2009-03-19

Bevacizumab
    End date: 2009-03-19

Filgrastim
    End date: 2009-03-19

Bevacizumab
    Dosage: 10 milligram
    Indication: Breast Cancer
    Start date: 2008-08-20
    End date: 2008-12-24

Doxorubicin HCL
    Dosage: 60 milligram
    Indication: Breast Cancer
    Start date: 2008-08-20
    End date: 2008-10-08

Pegfilgrastim
    Dosage: 6 milligram
    Indication: Breast Cancer
    Start date: 2008-08-20
    End date: 2008-09-01



Possible Abraxane side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-28

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 10 milligram/sq. meter
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Pegfilgrastim
    Dosage: 6 milligram
    End date: 2011-08-25

Other drugs received by patient: Benzonatate; Guaifenesin; Zolpidem; Cefepime; Famotidine; Prochlorperazine; Metoprolol Tartrate; Bacitracin; Fluconazole; Acetaminophen; Whole Blood



Possible Abraxane side effects in

Reported by a physician from United States on 2011-10-27

Patient:

Reactions: Nausea, Anaemia, Febrile Neutropenia, Peripheral Sensory Neuropathy, Fatigue, Alopecia, Sepsis, Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Abraxane
    Dosage: 100,125, or 150mg/m2
    Indication: Pancreatic Carcinoma

Gemcitabine
    Dosage: 1000 milligram/sq. meter



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017